Steve Krognes

Steve Krognes is a highly accomplished professional with a robust background in finance and business administration.

He holds a Master of Business Administration in Finance from Harvard Business School and a Bachelor of Science in Finance from the University of Pennsylvania.

Steve has held key roles in various esteemed organizations, including serving as a Board Member at Gritstone Oncology and previously at Argenx, Guardant Health, Denali Therapeutics, and Corvus Pharmaceuticals.

In addition to his board positions, he has a wealth of experience in executive leadership, having been the Chief Financial Officer at Denali Therapeutics and Genentech.

His expertise extends to mergers and acquisitions, where he has excelled in his roles at Roche and Danske Bank.

Steve's diverse professional journey also includes a stint as a Venture Capitalist at Pylonia Ventures and experience as a Management Consultant at McKinsey & Company.

Prior to his executive roles, he began his career as a Financial Analyst at Goldman Sachs, demonstrating a strong foundation in financial analysis and strategy.

He has also been involved in various capacities at prestigious organizations like the California Academy of Sciences and the California Life Science Association.

Steve's multifaceted background showcases his exceptional skills and expertise in finance, strategic planning, and corporate governance.